NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Tirzepatide from LSPL? Mail in a sample (US only) and let us test it.

Test my supply
+4 more ↓
77%
Finnrick rating
#154 of 281 Tirzepatide vendors
16 of 21 classifiable tests passed
customers 4.3★ (13)
methodology · Purity focus
Finnrick analysis · Tirzepatide

LSPL's tirzepatide record is held down by repeated purity misses, including 98.45% in January and 99.32%/99.3% in February-March. The latest results are cleaner, but batch detail gaps and fill swings keep the evidence mixed.

methodology →
vendor intelligence report
Vendor Intelligence Report: LSPL

Domain and corporate records trace LSPL from a Facebook-only surface to a ZZQ-linked email domain registered through a Chinese IT firm, without resolving the peptide owner. The report maps Quenna/MingYu/Yanmi identifiers, SEO hijacks to WhatsApp groups, forum-ban evidence, and COA disputes.

38 pages8 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
85%
6
2
Tirzepatideselected
$0.50
77%
21
3
Ipamorelin
$0.80
67%
3
4
Retatrutide
$0.55
64%
24
5
Cagrilintide
$2.00
61%
3
6
BPC-157
$2.40
-
0
8
GLOW
$0.23
-
0
9
PT-141
-
-
0
11
TB-500
$1.50
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%11 Jun 2025: 66%3 Aug 2025: 66%5 Aug 2025: 68%5 Aug 2025: 70%6 Nov 2025: 73%23 Nov 2025: 75%23 Nov 2025: 76%22 Dec 2025: 77%22 Dec 2025: 78%1 Jan 2026: 80%15 Jan 2026: 76%19 Jan 2026: 77%18 Feb 2026: 73%20 Feb 2026: 74%6 Mar 2026: 71%6 Mar 2026: 72%5 May 2026: 73%2 Jun 2026: 75%13 Jul 2026: 76%14 Jul 2026: 77%21 Jul 2026: 78%15 Nov 2026: current 77%66%77%77%Jun 25Nov 26
Showing Tirzepatide tests only
Peptide testing

Ordered Tirzepatide from LSPL? Mail in a sample (US only) and let us test it.

Test my supply
LSPL Tirzepatide test history
COA-backed lab tests
1-10 of 21

About LSPL test results from Finnrick

LSPL is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 57 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible LSPL peptides in this dataset are Cagrilintide (3 tests), GHK-Cu (6 tests) and Ipamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 57 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Tirzepatide from LSPL? Mail in a sample (US only) and let us test it.

Test my supply